Correlation of Smad4 status with outcomes in patients receiving erlotinib combined with adjuvant chemoradiation and chemotherapy after resection for pancreatic adenocarcinoma (Q38690359)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Correlation of Smad4 status with outcomes in patients receiving erlotinib combined with adjuvant chemoradiation and chemotherapy after resection for pancreatic adenocarcinoma |
scientific article |
Statements
1 reference
Correlation of Smad4 status with outcomes in patients receiving erlotinib combined with adjuvant chemoradiation and chemotherapy after resection for pancreatic adenocarcinoma (English)
1 reference
1 reference
Timothy M Pawlik
1 reference
Christine A Iacobuzio-Donahue
1 reference
Ralph H Hruban
1 reference
Christopher L Wolfgang
1 reference
John L Cameron
1 reference
Richard D Schulick
1 reference
Barish H Edil
1 reference
Ross C Donehower
1 reference
Daniel A Laheru
1 reference
Laura D Wood
1 reference
Michael A Choti
1 reference
Amanda L Blackford
1 reference
Katherine Y Fan
1 reference
Joseph M Herman
1 reference
Aaron T Wild
1 reference
1 November 2013
1 reference
1 reference
87
1 reference
458-459
1 reference
Identifiers
1 reference
1 reference
1 reference